about
BiP-mediated closing of the Sec61 channel limits Ca2+ leakage from the EREscherichia coli Subtilase CytotoxinThe B subunit of an AB5 toxin produced by Salmonella enterica serovar Typhi up-regulates chemokines, cytokines, and adhesion molecules in human macrophage, colonic epithelial, and brain microvascular endothelial cell linesChaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cellsIncorporation of a non-human glycan mediates human susceptibility to a bacterial toxinStructural Basis of Subtilase Cytotoxin SubAB AssemblyEcxAB is a founding member of a new family of metalloprotease AB5 toxins with a hybrid cholera-like B subunitCombined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcomaThe COG Complex, Rab6 and COPI Define a Novel Golgi Retrograde Trafficking Pathway that is Exploited by SubAB ToxinReactivity of convalescent-phase hemolytic-uremic syndrome patient sera with the megaplasmid-encoded TagA protein of Shiga toxigenic Escherichia coli O157A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.Clathrin-dependent trafficking of subtilase cytotoxin, a novel AB5 toxin that targets the endoplasmic reticulum chaperone BiP.Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways.Characterization of a novel type IV pilus locus encoded on the large plasmid of locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine originsPathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum.Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacementA dietary non-human sialic acid may facilitate hemolytic-uremic syndromeInhibition of water absorption and selective damage to human colonic mucosa are induced by subtilase cytotoxin produced by Escherichia coli O113:H21Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.Genomic Comparison of Two O111:H- Enterohemorrhagic Escherichia coli Isolates from a Historic Hemolytic-Uremic Syndrome Outbreak in Australia.The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia.The Pneumococcal Alpha-Glycerophosphate Oxidase Enhances Nasopharyngeal Colonization through Binding to Host Glycoconjugates.Escherichia coli subtilase cytotoxin induces apoptosis regulated by host Bcl-2 family proteins Bax/Bak.In Vivo leukocyte changes induced by Escherichia coli subtilase cytotoxin.Multiplex PCR for direct detection of Shiga toxigenic Escherichia coli strains producing the novel subtilase cytotoxinProtective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli.Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa.Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation.The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent.Structure, biological functions and applications of the AB5 toxins.Genetic diversity and virulence potential of shiga toxin-producing Escherichia coli O113:H21 strains isolated from clinical, environmental, and food sources.Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli.Differential effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on chemokine and proinflammatory cytokine expression in human macrophage, colonic epithelial, and brain microvascular endothelial cell lines.Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113:H21.Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsThe cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activityAction of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cellsDetection and characterization of STEC in stool samples using PCR.Methods for detection of STEC in humans. An overview.
P50
Q24293288-A3737081-DB27-45E5-B9BF-78256E99EA2DQ24604606-41AC6050-6793-4A33-B665-6ED68AE75E9AQ24614269-880A81A1-48B7-48AA-8DE6-62BDDB2E9D8BQ24648786-7AC12130-F2F2-4C69-BEFF-87D8D47EF675Q27652696-57009364-143D-4D7A-B4A4-5037C6DFD50DQ27679397-A9C1D60E-7F1E-4C28-800E-A11F52A27420Q27686921-7529C975-2B7A-455B-B7D3-9120DB7F7495Q28830095-5EEA4A41-A11F-4E9E-B4B9-FEB662488C59Q30047640-7EBB92AC-74CC-4926-9CFF-473E67D026AEQ30726762-2B815D82-7B45-4D76-8A5D-DA63FF01A8F1Q30940276-BDC96BCD-BE86-4B4F-B142-5CB18B516642Q31137905-1D2302F8-1DEB-4384-9192-4DA4F3FE995DQ33330462-9759B1ED-9E6C-4B1A-952A-D326ED86E084Q33342411-82DA1FE4-2F5F-49E3-8F64-F03725576192Q33347379-EA748A44-642B-4C8B-BE25-06BF2BC26845Q33376473-DEB1655A-18A7-4F07-BA6B-28C9CFBFCA19Q33383432-635729D9-AF16-4A99-BDCC-D6A28F2F4E28Q33384189-108EF97A-8BED-4A10-81A1-5E311CC4690CQ33408179-BE0B8046-0A82-417B-B36C-DF7302385D7FQ33415691-7EAFC104-2C6C-43BE-9215-BDB0E76B1E9DQ33428897-135EBD4B-146A-47D8-A220-F75A406F2128Q33556224-82906005-8434-4BE8-BBC4-2C5B94EE7DC2Q33603644-586A830B-81D1-436B-BB64-CACC4E83189CQ33659904-2721D5DC-62EC-400A-8E76-48CD2D36016BQ33808158-DBE97E93-776F-483B-8B1B-FB23CC7AE8C8Q33856439-E0A28579-F5B9-4521-BB97-DDD48D0B565EQ33883465-D7278577-842E-40E0-ABBE-B3526A8F5D4AQ33947146-F3CD99C9-E2B1-42F5-BA30-5735E1D6F50BQ33963113-2CED16F4-74DA-4EA2-BD56-E9092317CBFAQ34020348-2EC945F9-D499-480A-825B-919D10CAA38BQ34102115-1EDDD666-2820-4041-B443-6497AB36A0ADQ34107040-27BBA92C-ED4A-4FF8-917C-8837BFD75EA8Q34172935-D74B6F1B-DF5F-42F3-8DB6-00B9D4E3B80CQ34298345-3EA2BF3C-AFCC-4BD2-959E-B35F1A41EA42Q34491859-2AB033EA-CFBE-4759-BFB1-D1F89E5266BEQ34518407-B61E8441-83A2-44CC-980D-504DF6F9D2F6Q34709412-9820E9B2-8F5B-4E64-98D8-763A7DC82D0AQ34922868-15B3E5B1-3B7C-4C1A-B91D-510C95811F0DQ34957709-8B9828A5-0FB8-426B-A548-D0E16FDC794EQ34957772-8BA22C81-7B97-48EA-B1BE-24D5B5F535AA
P50
name
Adrienne W Paton
@en
type
label
Adrienne W Paton
@en
prefLabel
Adrienne W Paton
@en